Matthew Mei, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
    Relationship end date:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SeaGen
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
    Relationship end date:
    09/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ADC Therapeutics
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
    Relationship end date:
    09/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
    Relationship end date:
    09/13/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Synethekine
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
    Relationship end date:
    05/08/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BMS
    Topic:
    Research funding
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Beigene
    Topic:
    Research funding
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Incyte
    Topic:
    Research funding
    Date added:
    07/29/2024
    Date updated:
    07/29/2024
Return to Park City Myeloma and Lymphoma Summit